Portfolio Holdings Detail for ISIN IE00BFF5RZ82
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker IUMD(USD) LSE
ETF Ticker IUMD.L(GBP) LSE

Holdings detail for INCY

Stock Name	Incyte Corporation
Ticker	INCY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45337C1027
LEI	549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib: (RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update: Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY): Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00: Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY): Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC: Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY): Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY): Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY): Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY): State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY): Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY): Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY): Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus: Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) INCY holdings

Date	Number of INCY Shares Held	Base Market Value of INCY Shares	Local Market Value of INCY Shares	Change in INCY Shares Held	Change in INCY Base Value	Current Price per INCY Share Held	Previous Price per INCY Share Held
2025-12-03 (Wednesday)	4,049	USD 410,974	USD 410,974	0	USD 243	USD 101.5	USD 101.44
2025-12-02 (Tuesday)	4,049	USD 410,731	USD 410,731	0	USD -2,429	USD 101.44	USD 102.04
2025-12-01 (Monday)	4,049	USD 413,160	USD 413,160	-5	USD -10,321	USD 102.04	USD 104.46
2025-11-28 (Friday)	4,054	USD 423,481	USD 423,481	0	USD -4,824	USD 104.46	USD 105.65
2025-11-27 (Thursday)	4,054	USD 428,305	USD 428,305	0	USD 0	USD 105.65	USD 105.65
2025-11-26 (Wednesday)	4,054	USD 428,305	USD 428,305	0	USD 405	USD 105.65	USD 105.55
2025-11-25 (Tuesday)	4,054	USD 427,900	USD 427,900	0	USD -2,797	USD 105.55	USD 106.24
2025-11-24 (Monday)	4,054	USD 430,697	USD 430,697

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BFF5RZ82

Show aggregate share trades of INCY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-01 SELL -5 103.890 101.470 101.712 USD -509 68.21 Loss of -168 on sale
2025-05-29 SELL -107 66.040 66.260 66.238 USD -7,087 66.91 Profit of 72 on sale
2025-05-23 SELL -214 64.250 64.570 64.538 USD -13,811 66.99 Profit of 525 on sale
2025-05-22 SELL -214 64.510 65.330 65.248 USD -13,963 67.02 Profit of 378 on sale
2025-05-20 BUY 107 65.300 66.110 66.029 USD 7,065 67.05
2025-05-19 BUY 212 63.810 64.300 64.251 USD 13,621 67.08
2025-05-16 BUY 318 63.310 63.480 63.463 USD 20,181 67.12
2025-05-15 BUY 106 62.760 62.990 62.967 USD 6,675 67.16
2025-05-12 BUY 424 60.850 61.410 61.354 USD 26,014 67.35
2025-05-07 BUY 106 59.550 60.070 60.018 USD 6,362 67.59
2025-04-25 SELL -106 59.160 59.210 59.205 USD -6,276 68.19 Profit of 952 on sale
2025-04-23 BUY 106 58.000 59.010 58.909 USD 6,244 68.41
2025-04-22 BUY 106 57.380 58.040 57.974 USD 6,145 68.54
2025-04-15 SELL -318 58.460 59.950 59.801 USD -19,017 69.19 Profit of 2,987 on sale
2025-04-10 SELL -315 55.170 58.330 58.014 USD -18,274 69.66 Profit of 3,669 on sale
2025-04-07 SELL -106 60.290 61.060 60.983 USD -6,464 70.10 Profit of 966 on sale
2025-04-02 SELL -105 62.330 62.530 62.510 USD -6,564 70.34 Profit of 822 on sale
2025-04-01 BUY 105 60.910 62.000 61.891 USD 6,499 70.47
2025-03-31 SELL -210 60.550 60.810 60.784 USD -12,765 70.61 Profit of 2,063 on sale
2025-03-28 SELL -105 60.600 60.970 60.933 USD -6,398 70.75 Profit of 1,031 on sale
2025-03-25 SELL -105 62.080 63.270 63.151 USD -6,631 71.17 Profit of 842 on sale
2025-03-21 BUY 105 61.920 62.330 62.289 USD 6,540 71.44
2025-03-20 BUY 105 60.580 61.750 61.633 USD 6,471 71.61
2025-03-19 BUY 105 60.340 61.150 61.069 USD 6,412 71.79
2025-03-18 SELL -105 60.000 61.030 60.927 USD -6,397 71.98 Profit of 1,161 on sale
2025-03-17 BUY 210 62.010 63.450 63.306 USD 13,294 72.14
2025-03-13 SELL -105 67.710 68.970 68.844 USD -7,229 72.29 Profit of 362 on sale
2025-03-07 BUY 105 70.790 72.810 72.608 USD 7,624 72.50
2025-03-05 BUY 315 69.810 69.970 69.954 USD 22,036 72.55
2025-02-26 BUY 115 74.300 75.310 75.209 USD 8,649 72.59
2025-02-25 SELL -105 74.400 76.240 76.056 USD -7,986 72.55 Loss of -368 on sale
2025-02-21 SELL -105 72.110 72.970 72.884 USD -7,653 72.53 Loss of -38 on sale
2025-02-12 BUY 108 69.050 69.100 69.095 USD 7,462 72.91
2025-02-06 BUY 108 74.950 75.490 75.436 USD 8,147 73.14
2025-01-31 SELL -108 74.160 75.180 75.078 USD -8,108 72.98 Loss of -226 on sale
2025-01-29 SELL -108 73.720 74.110 74.071 USD -8,000 72.93 Loss of -123 on sale
2025-01-28 SELL -216 73.150 73.990 73.906 USD -15,964 72.92 Loss of -212 on sale
2025-01-24 BUY 321 72.590 73.680 73.571 USD 23,616 72.95
2025-01-23 SELL -216 72.530 72.880 72.845 USD -15,735 72.97 Profit of 26 on sale
2025-01-22 BUY 118 72.410 73.550 73.436 USD 8,665 72.99
2025-01-21 BUY 324 73.470 73.980 73.929 USD 23,953 72.97
2025-01-17 BUY 108 71.930 73.000 72.893 USD 7,872 73.07
2025-01-13 BUY 108 72.370 72.940 72.883 USD 7,871 73.24
2025-01-10 SELL -216 70.540 72.600 72.394 USD -15,637 73.41 Profit of 220 on sale
2025-01-08 BUY 214 73.130 74.010 73.922 USD 15,819 73.45
2024-12-30 SELL -107 68.420 68.870 68.825 USD -7,364 74.20 Profit of 575 on sale
2024-12-09 SELL -107 72.110 75.980 75.593 USD -8,088 74.58 Loss of -108 on sale
2024-12-06 BUY 212 75.920 76.460 76.406 USD 16,198 74.43
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-01	SELL	-5	103.890	101.470	101.712	USD -509	68.21 Loss of -168 on sale
2025-05-29	SELL	-107	66.040	66.260	66.238	USD -7,087	66.91 Profit of 72 on sale
2025-05-23	SELL	-214	64.250	64.570	64.538	USD -13,811	66.99 Profit of 525 on sale
2025-05-22	SELL	-214	64.510	65.330	65.248	USD -13,963	67.02 Profit of 378 on sale
2025-05-20	BUY	107	65.300	66.110	66.029	USD 7,065	67.05
2025-05-19	BUY	212	63.810	64.300	64.251	USD 13,621	67.08
2025-05-16	BUY	318	63.310	63.480	63.463	USD 20,181	67.12
2025-05-15	BUY	106	62.760	62.990	62.967	USD 6,675	67.16
2025-05-12	BUY	424	60.850	61.410	61.354	USD 26,014	67.35
2025-05-07	BUY	106	59.550	60.070	60.018	USD 6,362	67.59
2025-04-25	SELL	-106	59.160	59.210	59.205	USD -6,276	68.19 Profit of 952 on sale
2025-04-23	BUY	106	58.000	59.010	58.909	USD 6,244	68.41
2025-04-22	BUY	106	57.380	58.040	57.974	USD 6,145	68.54
2025-04-15	SELL	-318	58.460	59.950	59.801	USD -19,017	69.19 Profit of 2,987 on sale
2025-04-10	SELL	-315	55.170	58.330	58.014	USD -18,274	69.66 Profit of 3,669 on sale
2025-04-07	SELL	-106	60.290	61.060	60.983	USD -6,464	70.10 Profit of 966 on sale
2025-04-02	SELL	-105	62.330	62.530	62.510	USD -6,564	70.34 Profit of 822 on sale
2025-04-01	BUY	105	60.910	62.000	61.891	USD 6,499	70.47
2025-03-31	SELL	-210	60.550	60.810	60.784	USD -12,765	70.61 Profit of 2,063 on sale
2025-03-28	SELL	-105	60.600	60.970	60.933	USD -6,398	70.75 Profit of 1,031 on sale
2025-03-25	SELL	-105	62.080	63.270	63.151	USD -6,631	71.17 Profit of 842 on sale
2025-03-21	BUY	105	61.920	62.330	62.289	USD 6,540	71.44
2025-03-20	BUY	105	60.580	61.750	61.633	USD 6,471	71.61
2025-03-19	BUY	105	60.340	61.150	61.069	USD 6,412	71.79
2025-03-18	SELL	-105	60.000	61.030	60.927	USD -6,397	71.98 Profit of 1,161 on sale
2025-03-17	BUY	210	62.010	63.450	63.306	USD 13,294	72.14
2025-03-13	SELL	-105	67.710	68.970	68.844	USD -7,229	72.29 Profit of 362 on sale
2025-03-07	BUY	105	70.790	72.810	72.608	USD 7,624	72.50
2025-03-05	BUY	315	69.810	69.970	69.954	USD 22,036	72.55
2025-02-26	BUY	115	74.300	75.310	75.209	USD 8,649	72.59
2025-02-25	SELL	-105	74.400	76.240	76.056	USD -7,986	72.55 Loss of -368 on sale
2025-02-21	SELL	-105	72.110	72.970	72.884	USD -7,653	72.53 Loss of -38 on sale
2025-02-12	BUY	108	69.050	69.100	69.095	USD 7,462	72.91
2025-02-06	BUY	108	74.950	75.490	75.436	USD 8,147	73.14
2025-01-31	SELL	-108	74.160	75.180	75.078	USD -8,108	72.98 Loss of -226 on sale
2025-01-29	SELL	-108	73.720	74.110	74.071	USD -8,000	72.93 Loss of -123 on sale
2025-01-28	SELL	-216	73.150	73.990	73.906	USD -15,964	72.92 Loss of -212 on sale
2025-01-24	BUY	321	72.590	73.680	73.571	USD 23,616	72.95
2025-01-23	SELL	-216	72.530	72.880	72.845	USD -15,735	72.97 Profit of 26 on sale
2025-01-22	BUY	118	72.410	73.550	73.436	USD 8,665	72.99
2025-01-21	BUY	324	73.470	73.980	73.929	USD 23,953	72.97
2025-01-17	BUY	108	71.930	73.000	72.893	USD 7,872	73.07
2025-01-13	BUY	108	72.370	72.940	72.883	USD 7,871	73.24
2025-01-10	SELL	-216	70.540	72.600	72.394	USD -15,637	73.41 Profit of 220 on sale
2025-01-08	BUY	214	73.130	74.010	73.922	USD 15,819	73.45
2024-12-30	SELL	-107	68.420	68.870	68.825	USD -7,364	74.20 Profit of 575 on sale
2024-12-09	SELL	-107	72.110	75.980	75.593	USD -8,088	74.58 Loss of -108 on sale
2024-12-06	BUY	212	75.920	76.460	76.406	USD 16,198	74.43

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	321,923	395	451,110	71.4%
2025-09-18	244,947	1,423	469,747	52.1%
2025-09-17	277,858	779	546,953	50.8%
2025-09-16	359,781	946	576,379	62.4%
2025-09-15	347,453	4	582,228	59.7%
2025-09-12	353,040	0	631,534	55.9%
2025-09-11	448,733	3,894	739,701	60.7%
2025-09-10	490,727	248	671,932	73.0%
2025-09-09	515,395	1,822	682,791	75.5%
2025-09-08	308,184	119	479,828	64.2%
2025-09-05	256,719	2,505	512,049	50.1%
2025-09-04	422,624	1,507	834,717	50.6%
2025-09-03	381,679	7,777	624,922	61.1%
2025-09-02	547,120	15,396	816,267	67.0%
2025-08-29	148,294	262	304,427	48.7%
2025-08-28	164,008	0	347,480	47.2%
2025-08-27	248,926	453	513,401	48.5%
2025-08-26	365,130	6	709,320	51.5%
2025-08-25	478,130	1,306	642,319	74.4%
2025-08-22	344,352	2,023	596,301	57.7%
2025-08-21	198,729	4,881	335,301	59.3%
2025-08-20	351,699	3,977	555,345	63.3%
2025-08-19	343,110	3,146	574,328	59.7%
2025-08-18	366,124	4,996	653,103	56.1%
2025-08-15	480,885	8,035	625,797	76.8%
2025-08-14	593,554	36,654	806,068	73.6%
2025-08-13	845,181	98,160	1,257,503	67.2%
2025-08-12	462,896	42,208	678,689	68.2%
2025-08-11	385,211	696	595,892	64.6%
2025-08-08	248,925	738	426,187	58.4%
2025-08-07	268,864	929	420,486	63.9%
2025-08-06	554,642	891	731,484	75.8%
2025-08-05	361,687	2,092	623,879	58.0%
2025-08-04	338,005	1,464	519,150	65.1%
2025-08-01	414,814	828	572,879	72.4%
2025-07-31	570,845	6,148	777,417	73.4%
2025-07-30	471,303	14,166	881,194	53.5%
2025-07-29	966,640	10,581	1,593,701	60.7%
2025-07-28	382,236	62	625,510	61.1%
2025-07-25	216,967	49	422,990	51.3%
2025-07-24	348,276	23	528,517	65.9%
2025-07-23	297,903	583	487,297	61.1%
2025-07-22	267,987	172	446,489	60.0%
2025-07-21	223,626	380	406,729	55.0%
2025-07-18	241,218	108	471,589	51.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	IUMD(USD) LSE
ETF Ticker	IUMD.L(GBP) LSE